Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 12-2011 | 08-2011 | 08-2007 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 12 | N/A | N/A |
| TOTAL | $19 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 7 | N/A | N/A |
| TOTAL | $7 | $N/A | $N/A |
| Total Assets | $26 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 116 | 0 | 0 |
| Accrued Expenses | 16 | N/A | N/A |
| TOTAL | $141 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 7 | N/A | N/A |
| Other Non-Current Liabilities | 2,206 | 0 | 0 |
| TOTAL | $2,213 | $N/A | $N/A |
| Total Liabilities | $2,354 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 57 | N/A | N/A |
| Retained earnings | -16,371 | N/A | N/A |
| Other shareholders' equity | -291 | 0 | 0 |
| TOTAL | $-2,328 | $N/A | $N/A |
| Total Liabilities And Equity | $26 | $0 | $0 |